Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01963156 · ClinicalTrials.gov registry record · NA
Synchronization to Improve Non-Adherence to Cardiovascular Medications
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 3,675
- Enrollment target
NCT01963156: Clinical Trial NA study, sponsored by Brigham and Women's Hospital.
NCT01963156 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 3,675 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (162% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01963156, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 3,675 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate if synchronizing when patients with diabetes and/or coronary artery disease fill their prescriptions improves long-term adherence to these medications.
Primary Outcome
Average adherence to medications for the treatment of cardiovascular disease and diabetes medications as assessed using administrative pharmacy claims
Interventions
- BEHAVIORAL Prescription synchronization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,675 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-06 |
| Phase | NA |
Why NCT01963156 stopped before completion
NCT01963156 is an interventional study that assigns participants to a tested intervention. Its 3,675 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (162% higher).
The record links to 0 conditions, and to 1 intervention - of which Prescription synchronization is the first listed.
NCT01963156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01963156 about?
NCT01963156 is a clinical study titled "Synchronization to Improve Non-Adherence to Cardiovascular Medications". The aim of this study is to evaluate if synchronizing when patients with diabetes and/or coronary artery disease fill their prescriptions improves long-term adherence to these medications.
What is the current status of trial NCT01963156?
This trial is currently terminated. It is a NA study. The enrollment target is 3,675 participants. The study started on 2013-11. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01963156?
The interventions under investigation include: Prescription synchronization (BEHAVIORAL).
Who is sponsoring clinical trial NCT01963156?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01963156's enrollment target sits among peer trials
3,675 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia